Consolidated Cash Flow Statement

Profit after tax

Depreciation/amortization/impairment losses/reversals of impairment losses

Changes in inventories

Changes in trade accounts receivable

Changes in trade accounts payable/refund liabilities

Changes in provisions

Changes in other assets and liabilities

Neutralization of gains/losses on disposal of fixed assets and other disposals

Other non-cash income and expenses

Operating Cash Flow

Payments for investments in intangible assets

Proceeds from the disposal of intangible assets

Payments for investments in property, plant and equipment

Proceeds from the disposal of property, plant and equipment

Payments for investments in other assets

Proceeds from the disposal of other assets

Payments for acquisitions less acquired cash and cash equivalents (net)

Proceeds from divestments

Investing Cash Flow

Dividend payments to shareholders of Merck KGaA, Darmstadt, Germany

Dividend payments to non-controlling interests

Profit withdrawal by E. Merck KG, Darmstadt, Germany

Proceeds from new borrowings of financial debt from E. Merck KG, Darmstadt, Germany

Repayment of financial debt to E. Merck KG, Darmstadt, Germany, and E. Merck Beteiligungen KG, Darmstadt, Germany, a related party of E. Merck KG, Darmstadt, Germany

Proceeds from new borrowings of other current and non-current financial debt

Repayment of other current and non-current financial debt

Financing Cash Flow

Changes in cash and cash equivalents

Changes in cash and cash equivalents due to currency translation

Cash and cash equivalents as of January 1

Cash and cash equivalents as of December 31 (Consolidated Balance Sheet)